Advances in hepatitis C virus vaccines, Part one: Advances in basic knowledge for hepatitis C virus vaccine design (Q37948856)

25 August 2017

Advances in hepatitis C virus vaccines, Part one: Advances in basic knowledge for hepatitis C virus vaccine design (English)

1 reference

25 August 2017

1 reference

1 reference

1 reference

Farzin Roohvand

1

1 reference

PubMed ID

22022980

25 August 2017

Niloufar Kossari

series ordinal

2

1 reference

PubMed ID

22022980

25 August 2017

language of work or name

English

0 references

publication date

25 October 2011

1 reference

Expert Opinion on Therapeutic Patents

25 August 2017

1 reference

25 August 2017

21

1 reference

25 August 2017

12

1 reference

25 August 2017

1811-1830

1 reference

The natural history of hepatitis C virus infection: host, viral, and environmental factors

25 August 2017

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2011.630662

Epidemiology of hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2011.630662

Transfusion-Associated Hepatitis Not Due to Viral Hepatitis Type A or B

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2011.630662

Sporadic non-A, non-B hepatitis: frequency and epidemiology in an urban U.S. population

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2011.630662

Unsafe sex and increased incidence of hepatitis C virus infection among HIV-infected men who have sex with men: the Swiss HIV Cohort Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2011.630662

Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2011.630662

Consensus proposals for a unified system of nomenclature of hepatitis C virus genotypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2011.630662

Evolving epidemiology of hepatitis C virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2011.630662

Complete replication of hepatitis C virus in cell culture

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2011.630662

Human occludin is a hepatitis C virus entry factor required for infection of mouse cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2011.630662

Lamiridosins, hepatitis C virus entry inhibitors from Lamium album.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2011.630662

Treating viral hepatitis C: efficacy, side effects, and complications

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2011.630662

Cost-effectiveness of combination peginterferon alpha-2a and ribavirin compared with interferon alpha-2b and ribavirin in patients with chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2011.630662

Prospects for a vaccine against the hepatitis C virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2011.630662

Development of hepatitis C virus vaccines: challenges and progress.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2011.630662

Hepatitis C virus replication in mice with chimeric human livers

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2011.630662

Discovery of the hepatitis C virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2011.630662

21 January 2018

Viruses and interferons

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2011.630662

Immune responses during acute and chronic infection with hepatitis C virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2011.630662

Characterization of the cellular immune response in hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2011.630662

CD8+ T cell tolerance following antigen recognition on hepatocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2011.630662

Differential antigenic hierarchy associated with spontaneous recovery from hepatitis C virus infection: implications for vaccine design

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2011.630662

Meta-analysis of hepatitis C virus vaccine efficacy in chimpanzees indicates an importance for structural proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2011.630662

High resolution analysis of cellular immune responses in resolved and persistent hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2011.630662

Broad repertoire of the CD4+ Th cell response in spontaneously controlled hepatitis C virus infection includes dominant and highly promiscuous epitopes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2011.630662

Impaired effector function of hepatitis C virus-specific CD8+ T cells in chronic hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2011.630662

Analysis of a successful immune response against hepatitis C virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2011.630662

Cellular immunity to hepatitis C virus core protein and the response to interferon in patients with chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2011.630662

Outcome of acute hepatitis C is related to virus-specific CD4 function and maturation of antiviral memory CD8 responses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2011.630662

Ex vivo analysis of human memory CD4 T cells specific for hepatitis C virus using MHC class II tetramers

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2011.630662

Construction of HCV-polytope vaccine candidates harbouring immune-enhancer sequences and primary evaluation of their immunogenicity in BALB/c mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2011.630662

Polytope DNA vaccine development against hepatitis C virus: a streamlined approach from in silico design to in vitro and primary in vivo analyses in BALB/c mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2011.630662

Fusion of HBsAg and prime/boosting augment Th1 and CTL responses to HCV polytope DNA vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2011.630662

Properties of the hepatitis C virus core protein: a structural protein that modulates cellular processes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2011.630662

Initiation of Hepatitis C Virus Infection Requires the Dynamic Microtubule Network: ROLE OF THE VIRAL NUCLEOCAPSID PROTEIN

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2011.630662

Morphological changes in intracellular lipid droplets induced by different hepatitis C virus genotype core sequences and relationship with steatosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2011.630662

Mutations in the hepatitis C virus core gene are associated with advanced liver disease and hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2011.630662

Hepatitis C virus core protein leads to immune suppression and liver damage in a transgenic murine model

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2011.630662

Hepatitis C virus core protein exerts an inhibitory effect on suppressor of cytokine signaling (SOCS)-1 gene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2011.630662

Hepatitis C virus core protein blocks interferon signaling by interaction with the STAT1 SH2 domain

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2011.630662

Hepatitis C virus variants circumventing cytotoxic T lymphocyte activity as a mechanism of chronicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2011.630662

Immune selection and genetic sequence variation in core and envelope regions of hepatitis C virus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2011.630662

HCV core protein immunization with Montanide/CpG elicits strong Th1/Th2 and long-lived CTL responses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2011.630662

Ribosomal frameshifting viral RNAs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2011.630662

Evidence for a new hepatitis C virus antigen encoded in an overlapping reading frame

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2011.630662

The HCV ARFP/F/core+1 protein: production and functional analysis of an unconventional viral product

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2011.630662

Ribosomal scanning past the primary initiation codon as a mechanism for expression of CTL epitopes encoded in alternative reading frames

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2011.630662

Cyanovirin-N inhibits hepatitis C virus entry by binding to envelope protein glycans

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2011.630662

Binding of the Hepatitis C Virus Envelope Protein E2 to CD81 Inhibits Natural Killer Cell Functions

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2011.630662

Neutralizing antibody response during acute and chronic hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2011.630662

Hypervariable region 1 differentially impacts viability of hepatitis C virus strains of genotypes 1 to 6 and impairs virus neutralization

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2011.630662

Hepatitis C virus continuously escapes from neutralizing antibody and T-cell responses during chronic infection in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2011.630662

The Neutralizing Activity of Anti-Hepatitis C Virus Antibodies Is Modulated by Specific Glycans on the E2 Envelope Protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2011.630662

Hepatitis C virus and other flaviviridae viruses enter cells via low density lipoprotein receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2011.630662

Immunogenicity and tolerability of intradermal administration of an HCV E1-based vaccine candidate in healthy volunteers and patients with resolved or ongoing chronic HCV infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2011.630662

Depletion of interfering antibodies in chronic hepatitis C patients and vaccinated chimpanzees reveals broad cross-genotype neutralizing activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2011.630662

Identification of a Broadly Cross-Reacting and Neutralizing Human Monoclonal Antibody Directed against the Hepatitis C Virus E2 Protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2011.630662

Isolation and Characterization of Broadly Neutralizing Human Monoclonal Antibodies to the E1 Glycoprotein of Hepatitis C Virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2011.630662

Broadly neutralizing antibodies protect against hepatitis C virus quasispecies challenge

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2011.630662

Construction and characterization of infectious intragenotypic and intergenotypic hepatitis C virus chimeras

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2011.630662

Stable Cytotoxic T Cell Escape Mutation in Hepatitis C Virus Is Linked to Maintenance of Viral Fitness

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2011.630662

Allelic Variation in the Hepatitis C Virus NS4B Protein Dramatically Influences RNA Replication

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2011.630662

Regulation of Hepatitis C Virion Production via Phosphorylation of the NS5A Protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2011.630662

The hepatitis C virus non-structural NS5A protein impairs both the innate and adaptive hepatic immune response in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2011.630662

Identification of Hepatitis C Virus NS5A Inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2011.630662

Genetic heterogeneity of hepatitis C virus: quasispecies and genotypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2011.630662

Host and viral factors in the immunopathogenesis of primary hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2011.630662

Rapid induction of virus-neutralizing antibodies and viral clearance in a single-source outbreak of hepatitis C

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2011.630662

Sustained E2 antibody response correlates with reduced peak viremia after hepatitis C virus infection in the chimpanzee

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2011.630662

Spontaneous control of primary hepatitis C virus infection and immunity against persistent reinfection

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2011.630662

HCV Persistence and Immune Evasion in the Absence of Memory T Cell Help

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2011.630662

Adaptive immune responses in acute and chronic hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2011.630662

Preferential loss of IL-2-secreting CD4+ T helper cells in chronic HCV infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2011.630662

Impact of the genetic restriction of virus-specific T-cell responses in hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2011.630662

Genetic variation in IL28B and spontaneous clearance of hepatitis C virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2011.630662

Silencing of USP18 potentiates the antiviral activity of interferon against hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2011.630662

A T-cell HCV vaccine eliciting effective immunity against heterologous virus challenge in chimpanzees

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2011.630662

T-cell vaccines that elicit effective immune responses against HCV in chimpanzees may create greater immune pressure for viral mutation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2011.630662

Programmed death-1 affects suppressor of cytokine signaling-1 expression in T cells during hepatitis C infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2011.630662

Cross-talk between programmed death-1 and suppressor of cytokine signaling-1 in inhibition of IL-12 production by monocytes/macrophages in hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2011.630662

Reduced naive CD4 T cell numbers and impaired induction of CD27 in response to T cell receptor stimulation reflect a state of immune activation in chronic hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2011.630662

Functional suppression by FoxP3+CD4+CD25(high) regulatory T cells during acute hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2011.630662

Characterization and role of intra-hepatic regulatory T cells in chronic hepatitis C pathogenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2011.630662

High Level of PD-1 Expression on Hepatitis C Virus (HCV)-Specific CD8+ and CD4+ T Cells during Acute HCV Infection, Irrespective of Clinical Outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2011.630662

Cross-genotype immunity to hepatitis C virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2011.630662

Development of JFH1-based cell culture systems for hepatitis C virus genotype 4a and evidence for cross-genotype neutralization

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2011.630662

Biological properties of purified recombinant HCV particles with an epitope-tagged envelope

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2011.630662

Animal models in the study of hepatitis C virus-associated liver pathologies

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2011.630662

Animal models for studying hepatitis C and alcohol effects on liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2011.630662

10.1517/13543776.2011.630662

21 January 2018

Identifiers

DOI

1 reference

25 August 2017

1 reference

PubMed ID

22022980